144 filed Apr 1, 2026 at 10:53 ET
Paul Rubin, an officer of BioAge Labs, filed a Form 144 notifying intent to sell up to 8,820 shares of common stock, exercisable via two stock options granted in 2020 and 2022, with the sale date reported as April 1, 2026. The filing reflects a planned exercise and sale of vested options, not an immediate large-scale disposition of existing holdings. Given the officer status and full exercise of available options, this signals moderate insider activity but is not unusually large in magnitude relative to market cap.